Perceptic raises $12m seed round to build unified AI platform for drug development

Perceptic has raised $12m (£9m) in seed funding led by Accel, Air Street Capital, and Elder Gull to develop a unified AI system that integrates research, development, and clinical decision-making across the entire drug lifecycle. The company aims to address the fragmented nature